Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice

Neuroscience Letters
J FadelAriel Y Deutch

Abstract

Neurotensin (NT) has been suggested to interact with dopamine systems in different forebrain sites to exert both antipsychotic- and psychostimulant-like effects. We previously found that genetic or pharmacological manipulations that disrupt endogenous NT signaling attenuate antipsychotic drug-induced Fos expression in the dorsolateral and central striatum but not other striatal regions. To assess the role of NT in psychostimulant responses, we examined the ability of d-amphetamine (AMP) to induce Fos in wild-type and NT null mutant mice. AMP-elicited Fos expression was significantly attenuated in the medial striatum of NT null mutant mice, but was unaffected in other striatal territories. Similar results were obtained in rats and mice pretreated with the high affinity neurotensin receptor (NTR1) antagonist SR 48692. The effect of the NTR1 antagonist was particularly apparent in the striatal patch (striosome) compartment, as defined by mu-opioid receptor immunoreactivity. These data suggest that NT is required for the full activation by AMP of medial striatal neurons.

References

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A M GraybielH A Robertson
Apr 1, 1994·The European Journal of Neuroscience·M N CastelT Hökfelt
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D GullyA Brouard
Jul 1, 1997·The American Journal of Psychiatry·R P SharmaC B Nemeroff
Dec 23, 1998·The Journal of Comparative Neurology·M J Alexander, S E Leeman
Jun 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·P R DobnerA Y Deutch
Dec 26, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Fany PanayiAnne Bérod
Jan 12, 2002·Current Opinion in Pharmacology·Anne Bérod, William Rostène
Jun 13, 2003·Life Sciences·Paul R DobnerJim Fadel
Jan 30, 2004·Learning & Memory·Michael E Ragozzino, Daniel Choi
Jan 22, 2005·Brain Research. Molecular Brain Research·David H AdamsKristen A Keefe
Jul 1, 2005·The Journal of Pharmacology and Experimental Therapeutics·Becky KinkeadCharles B Nemeroff

❮ Previous
Next ❯

Citations

Jul 2, 2011·Psychopharmacology·F Scott HallGeorge R Uhl
Jan 13, 2016·Journal of Psychopharmacology·Luca FerraroMalgorzata Filip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here